Three draft recommendation documents published on Wednesday are intended to guide drug sponsors and accelerate the ...
SciTech Development Inc., a clinical-stage oncology company in Detroit, has closed its Convertible Note Round No. 3 (CNR 3) ...
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...
Lineage Cell Therapeutics, Inc. (NYSE:LCTX) is a clinical-stage biotech company developing allogeneic “off-the-shelf” cell ...
X™ T-Cell Transduction Sponge is honored in the Lab Research Tools category of the 2025 Top Innovations contest.
TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability.The platform has achieved ...
At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.
Cancer cells are pretty bold and clever—they hijack cellular survival and healing processes in order to fuel their growth, ...
Professor Adam Paré's research identifies the fundamental mechanisms that mold tissues during animal development. On Wednesday, he will discuss epithelial remodeling during development.
The initial focus is on “high-end” yachting sector, with plans to target the broader maritime industry and other markets.